Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Bjerager

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
JAMA Ophthalmology|September 19, 2024
Real-Time Visualization of a Transient Retinal EmbolusJakob Bjerager, Morten Jørgensen, Steffen Hamann
JAMA Ophthalmology|September 28, 2023
Laser-Induced Chorioretinal Anastomosis in Neurofibromatosis Type 1Jakob Bjerager, Pascal W Hasler, Peter M Maloca, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 9, 2024
Systemic adverse events and all-cause mortality following same-session bilateral intravitreal anti-VEGF injections: a systematic reviewJakob Bjerager, Javad Hajari, Oliver Niels Klefter, et al.
International Ophthalmology|February 9, 2024
Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic reviewJakob Bjerager, Javad Hajari, Oliver Niels Klefter, et al.
Ugeskrift for Laeger|July 3, 2026
[Risk of developing cataract related to fluoroscopy]Jens Peter Ellekilde Bonde, Jakob Bjerager, Ingrid Sivesind Mehlum, et al.
Acta Ophthalmologica|May 17, 2021
Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial dataYousif Subhi, Jakob Bjerager, Camiel J F Boon, et al.
Ophthalmology and Therapy|May 9, 2026
Durability of Three Monthly Loading Doses with Faricimab in Treatment-Naïve Neovascular Age-Related Macular DegenerationLeyla Turan, Jakob Bjerager, Yousif Subhi, et al.
Plos One|September 9, 2021
Lens fluorescence and skin fluorescence in the Copenhagen Twin Cohort Eye Study: Covariates and heritabilityJakob Bjerager, Sami Dabbah, Mohamed Belmouhand, et al.
Acta Ophthalmologica|January 21, 2022
Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysisJakob Bjerager, Elon H C van Dijk, Lars Morten Holm, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2024
Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degenerationMiklos Schneider, Jakob Bjerager, Delila Hodzic-Hadzibegovic, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
JAMA Ophthalmology|September 19, 2024
Real-Time Visualization of a Transient Retinal EmbolusJakob Bjerager, Morten Jørgensen, Steffen Hamann
JAMA Ophthalmology|September 28, 2023
Laser-Induced Chorioretinal Anastomosis in Neurofibromatosis Type 1Jakob Bjerager, Pascal W Hasler, Peter M Maloca, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 9, 2024
Systemic adverse events and all-cause mortality following same-session bilateral intravitreal anti-VEGF injections: a systematic reviewJakob Bjerager, Javad Hajari, Oliver Niels Klefter, et al.
International Ophthalmology|February 9, 2024
Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic reviewJakob Bjerager, Javad Hajari, Oliver Niels Klefter, et al.
Ugeskrift for Laeger|July 3, 2026
[Risk of developing cataract related to fluoroscopy]Jens Peter Ellekilde Bonde, Jakob Bjerager, Ingrid Sivesind Mehlum, et al.
Acta Ophthalmologica|May 17, 2021
Subretinal fluid morphology in chronic central serous chorioretinopathy and its relationship to treatment: a retrospective analysis on PLACE trial dataYousif Subhi, Jakob Bjerager, Camiel J F Boon, et al.
Ophthalmology and Therapy|May 9, 2026
Durability of Three Monthly Loading Doses with Faricimab in Treatment-Naïve Neovascular Age-Related Macular DegenerationLeyla Turan, Jakob Bjerager, Yousif Subhi, et al.
Plos One|September 9, 2021
Lens fluorescence and skin fluorescence in the Copenhagen Twin Cohort Eye Study: Covariates and heritabilityJakob Bjerager, Sami Dabbah, Mohamed Belmouhand, et al.
Acta Ophthalmologica|January 21, 2022
Previous intravitreal injection as a risk factor of posterior capsule rupture in cataract surgery: a systematic review and meta-analysisJakob Bjerager, Elon H C van Dijk, Lars Morten Holm, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|February 28, 2024
Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degenerationMiklos Schneider, Jakob Bjerager, Delila Hodzic-Hadzibegovic, et al.
Pageof 3